Idiopathic Multifocal Choroiditis - Cause, Diagnosis, and Treatment

Introduction

Idiopathic multifocal choroiditis syndromes are uncommon illnesses. Alex Krill and colleagues were the first to adopt the term "multifocal choroiditis" (MFC) to characterize a non-infectious, idiopathic ocular condition similar to "presumed ocular histoplasmosis syndrome" (POHS) in 1969. In 1973, Nozik and Dorsch documented a similar chorioretinopathy accompanied by anterior uveitis in two individuals with fundus lesions comparable to POHS but with vitreous and anterior chamber inflammation but no signs of infectious illness.

What Is the Cause of Idiopathic Multifocal Choroiditis?

The cause of idiopathic multifocal choroiditis is uncertain. A previous infection may have triggered the immunological response seen in multifocal choroiditis. Because IMFC can mimic other uveitic diseases caused by systemic, viral, or malignant illness, it is critical to address these individuals with a broad differential. The selection of clinical therapy is dependent on a correct diagnosis. Most IMFC patients are myopic, and ocular involvement is usually bilateral. IMFC primarily affects healthy people who have no known systemic or ocular illness.

How Does Idiopathic Multifocal Choroiditis Progress?

• Idiopathic multifocal choroiditis is a persistent and progressive bilateral inflammatory condition with choroidal neovascularization and chorioretinal atrophy.

• The retinal pigment epithelium (RPE), outer retinal spaces, choriocapillaris, and, less frequently, the choroid, the choroidal stroma, are the most usually afflicted locations.

• Chorioretinal lesions can be found across the posterior pole and peripheral retina. There is a mild to severe anterior chamber cell response.

• Vitritis is usually detected in one or both eyes and effectively eliminates POHS as a diagnosis.

• Active, inactive, secondary active choroidal neovascularization, and secondary inactive choroidal neovascularization are the four forms of multifocal choroiditis lesions that can occur.

• Previously, clinicians classified MFC lesions based on alterations in visual acuity, vitreous inflammatory cells, and localized pigmentation.

• However, more than this unstandardized method was needed to guide therapy.

• Idiopathic MFC has been linked to interleukin-10 and tumor necrosis factor haplotypes. However, the precise mechanism of IMFC is yet uncertain.

• It is hypothesized that previous infection is to blame for the observed immune response in IMFC.

• Inflammatory lesions begin in the retinal pigment epithelium and choroidal capillaries. Some believe a foreign pathogen sensitizes antigens in the retinal photoreceptors and RPE.

• These inflammatory lesions can then compromise the integrity of Bruch's membrane, the choroid's innermost layer.

• This allows for the forming of a choroidal neovascular membrane, which can occur in as many as sixty percent of individuals. There is no advised prevention since no identifiable etiology is related to the disease processes.

How Is Idiopathic Multifocal Choroiditis Diagnosed?

A clinical diagnosis of idiopathic multifocal choroiditis exists. MFC has a wide range of differential diagnoses. As IMFC is an exclusion diagnosis, excluding similar seeming ocular diseases, exceptionally infectious, neoplastic, and systemic disorders are critical. Scotoma may be present during visual field testing. A slit-lamp examination shows intraocular inflammation and anterior or vitreous cells. Retinal examination indicates yellow to gray lesions at the retinal pigment epithelium and choriocapillaris levels. The lesions range in size from 45 to 350 m. Lesions can spread throughout the retina, in clusters, or along a line. During active disease, the exam may reveal subretinal fluid, optic nerve swelling and hyperemia, cystoid macular edema, atrophic, punched-out discolored retinal pigment epithelium lesions, or choroidal neovascularization. The most severe consequence of the condition, choroidal neovascularization, may develop during the acute phase. In 14 to 41 percent of afflicted eyes, cystoid macular edema develops. IMFC can cause glaucoma, optic nerve atrophy, macular atrophy, vitritis, and progressive subretinal scarring. Retinal imaging can help determine the kind of lesion. It is advised that different imaging modalities be used in diagnosis.

1. Color fundus photography is utilized. Active lesions are yellow-white. Due to retinal edema, the margins of the lesions may become indistinct. Occasionally, punctate hemorrhaging might be seen. Inactive lesions are generally gray, and their borders are more distinct. Scar fibrosis and pigmentation, on the other hand, are standard on these lesions.

2. Late-phase fluorescein fundus angiography demonstrating arteriolar attenuation and late staining of choroidal lesions. Acute inflammatory lesions have minimal early and late hyperfluorescence staining. The appearance of late staining may suggest the existence of an active CNV.

3. OCT stands for optical coherence tomography. Active lesions have elevated retinal protrusion due to material deposition in the sub-RPE space. Under the active lesions, choroidal thickness may be noticed on EDI-OCT. CNV is indicated by subretinal or sub-RPE material with accompanying fluid.

4. Angiography using indocyanine green indicates acute inflammatory lesions are often characterized by mild early hypofluorescence that becomes more apparent later in the research. Active CNV is characterized by late hyperfluorescence.

5. Fundus autofluorescence (FAF) imaging reveals extensive hyper-autofluorescent lesions in the peripapillary and posterior poles and late staining of the optic nerve. FAF may develop hypo auto fluorescent atrophic lesions when the inflammation resolves.

6. Electroretinogram has a wide variety of outcomes, with some individuals having normal ERG findings and others having lower a and b wave amplitudes.

How Is Idiopathic Multifocal Choroiditis Treated?

• Treatment for IMFC is individualized based on the amount of inflammation, the formation of active inflammatory lesions, comorbidities, and impaired visual acuity.

• The development of cystoid macular edema, thick vitreous, or choroidal neovascular membrane indicates treatment.

• Management focuses on reducing inflammation and choroidal neovascularization. The severity of the disease determines treatment; nevertheless, corticosteroids or other immunosuppressive medicines are commonly utilized.

• Oral corticosteroids are frequently used as the first line of therapy.

• They are usually given at a high to moderate dose and then gradually reduced when the inflammation subsides.

• Local anti-inflammatory treatment may include periocular or intraocular corticosteroid injections or implants.

• Dexamethasone is an intravitreal injection to treat non-infectious posterior segment uveitis. The average duration of action is three to four months.

Conclusion

Idiopathic multifocal choroiditis (IMFC) is a rare inflammatory disorder characterized by numerous retina and choroidal tissue lesions. IMCP produces inflammatory bouts that can occur bilaterally, concurrently, or independently. Previously, this illness was known as punctate inner choroidopathy, multifocal choroiditis with panuveitis, and progressive subretinal fibrosis with uveitis syndrome. However, IMFC is distinct from the other disease processes. The etiology is thought to be either a vasculitic occlusion of the choriocapillaris with consequent RPE infarction or an immune reaction aimed at the RPE itself. Many clinical symptoms of the various syndromes overlap, generating considerable misunderstanding. It is unclear if these disorders are independent entities or portions of a spectrum of the same underlying sickness.